Table 2.
Category | Keywords | Additional common words (in abstract or title) | Additional parameters based on most common non-relevant hits |
Population | Parkinson’s disease OR human OR patients OR aged | Subject* OR Participant* | |
Intervention | Therapy OR Disease Progression | Neuroprotect* OR Delay* OR Improv* OR Treatment | |
Comparator | Random allocation OR Control groups OR placebo | ||
Outcome | Safety OR adverse | Efficacy OR benefit OR slow OR risk | NOT ‘deep brain stimulation’ NOT ‘predict* model’ |
Study design | Clinical trial | Study OR Phase |